Royal Fund Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Royal Fund Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-136	Closed	-$17K	–	276
2020 Q1	$17K	Hold	136	–	–	0.01%	309
2019 Q4	$20K	Hold	136	–	–	0.01%	337
2019 Q3	$16K	Hold	136	–	–	﹤0.01%	359
2019 Q2	$19K	Hold	136	–	–	0.01%	325
2019 Q1	$20K	Hold	136	–	–	0.01%	298
2018 Q4	$16K	Hold	136	–	–	0.01%	289
2018 Q3	$21K	Buy	136 +122	+871%	+$18.5K	0.01%	267
2018 Q2	$1K	Hold	14	–	–	﹤0.01%	515
2018 Q1	$1K	Sell	14 -207	-94%	-$28.3K	﹤0.01%	485
2017 Q4	$27K	Hold	221	–	–	0.01%	256
2017 Q3	$27K	Hold	221	–	–	0.01%	215
2017 Q2	$25K	Hold	221	–	–	0.01%	202
2017 Q1	$23K	Buy	221 +207	+1,479%	+$20.7K	0.01%	203
2016 Q4	$1K	Buy	+14	New	+$1.31K	﹤0.01%	367

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Royal Fund Management's FBT Position: Q2 2020 in Review

Royal Fund Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2020, closing a stake of 136 shares — an estimated $17K sold.

Royal Fund Management first reported a position in FBT in Q4 2016 and held it in 14 quarters. The position peaked at $27K in Q4 2017. 224 funds tracked by Wall St. Rank hold FBT as of Q2 2020.

Royal Fund Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2020 after selling out during the quarter.
Royal Fund Management sold 136 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2020, an estimated $17K.
Royal Fund Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2016 and held it in 14 quarters.
Royal Fund Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $27K in Q4 2017.
224 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2020.

Based on Royal Fund Management's 13F filing for Q2 2020, filed 6 Aug 2020.